The Role of Maintenance CD20 Antibodies and Risk Factors for Transformation

The role of maintenance CD20 antibodies in treating follicular lymphoma is discussed, including the results of the Prima study and considerations for clinicians regarding prolonged progression-free survival, increased toxicity, risk factors for transformation, and management of relapse disease.